Novacyt Group, an international specialist in cancer and infectious diseases, has diversified sales from diagnostic products used in LBC, oncology, microbiology, haematology and serology testing.

We support a large global customer base which includes hospitals to large corporates. Our proprietary technology platform NOVAPREP® is a unique next generation liquid based cytology solution focused on cancer management.

Type
Public
HQ
Vélizy-Villacoublay, FR
Employees
67 (est)
Novacyt is headquartered in Vélizy-Villacoublay, FR

Novacyt Locations

Vélizy-Villacoublay, FR
Milton, GB

Novacyt Metrics

Novacyt Summary

Market capitalization

€10.6 M

Closing share price

€1.11
Novacyt's latest market capitalization is €10.6 M.

Novacyt Market Value History

Novacyt Company Life